C07D 213/72
Nitrogen atoms
Official title: Nitrogen atoms (nitro radicals C07D213/61)
C07D213/72 (Nitrogen atoms) appears on 5,035 US grants and 4,853 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,035
- Published applications
- 4,853
- Assignees
- 1,920
- Inventors
- 14,858
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 50 | 0 |
| 1977 | 70 | 0 |
| 1978 | 50 | 0 |
| 1979 | 46 | 0 |
| 1980 | 48 | 0 |
| 1981 | 61 | 0 |
| 1982 | 43 | 0 |
| 1983 | 36 | 0 |
| 1984 | 48 | 0 |
| 1985 | 66 | 0 |
| 1986 | 52 | 0 |
| 1987 | 51 | 0 |
| 1988 | 49 | 0 |
| 1989 | 63 | 0 |
| 1990 | 73 | 0 |
| 1991 | 71 | 0 |
| 1992 | 66 | 0 |
| 1993 | 64 | 0 |
| 1994 | 59 | 0 |
| 1995 | 68 | 0 |
| 1996 | 92 | 0 |
| 1997 | 91 | 0 |
| 1998 | 77 | 0 |
| 1999 | 101 | 0 |
| 2000 | 95 | 0 |
| 2001 | 117 | 38 |
| 2002 | 139 | 150 |
| 2003 | 135 | 205 |
| 2004 | 104 | 267 |
| 2005 | 103 | 221 |
| 2006 | 138 | 232 |
| 2007 | 135 | 205 |
| 2008 | 111 | 180 |
| 2009 | 127 | 227 |
| 2010 | 144 | 238 |
| 2011 | 149 | 205 |
| 2012 | 148 | 200 |
| 2013 | 165 | 201 |
| 2014 | 190 | 266 |
| 2015 | 219 | 246 |
| 2016 | 162 | 209 |
| 2017 | 206 | 201 |
| 2018 | 149 | 176 |
| 2019 | 148 | 149 |
| 2020 | 128 | 165 |
| 2021 | 104 | 157 |
| 2022 | 109 | 167 |
| 2023 | 70 | 154 |
| 2024 | 79 | 173 |
| 2025 | 101 | 127 |
| 2026 | 65 | 94 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Reagent for mass spectrometry29 Sep 2026US 12,748,116 B2Roche Diagnostics Operations, Inc.
- Lipoxygenase inhibitors22 Sep 2026US 12,741,926 B2SRI International
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Arylsulfonamides as orexin receptor agonists8 Sep 2026US 12,729,178 B2Research Triangle Institute
- Bicyclic compounds8 Oct 2026US 2026/0308114 A1Vivace Therapeutics, Inc.
- Neuroactive androgen receptor modulators and use thereof1 Oct 2026US 2026/0294908 A1ENDOCHEM PHARMACEUTICALS (BEIJING) CO., LTD. Beijing
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Inhibitors of spinster homolog 2 (spns2) for use in therapy1 Oct 2026US 2026/0297044 A1University of Virginia Patent Foundation
- Inhibitors of Notch Signaling Pathway and Use Thereof in Treatment of Cancers1 Oct 2026US 2026/0297082 A1Cellestia Biotech AG
Most cited
By later US patents
- Intermediates for imidazo[4,5-c]pyridin-4-amines248US 5,446,153 AMinnesota Mining and Manufacturing Company · 1995
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007
- Platinum complex and light emitting device154US 7,442,797 B2Takasago International Corporation · 2008
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008